Details for Patent: 10,793,893
✉ Email this page to a colleague
Which drugs does patent 10,793,893 protect, and when does it expire?
Patent 10,793,893 protects FIRDAPSE and is included in one NDA.
This patent has two patent family members in two countries.
Summary for Patent: 10,793,893
Title: | Methods of administering 3,4-diaminopyridine |
Abstract: | Provided herein are methods of determining NAT acetylation status of a subject with a 3,4-DAP-sensitive disease, methods of selecting a dose of 3,4-DAP or a pharmaceutically acceptable salt thereof adjusted to a subject's acetylation status, methods of administering 3,4-diaminopyridine or a pharmaceutically acceptable salt thereof to a patient in need thereof, and methods of treating 3,4-DAP sensitive diseases. |
Inventor(s): | Garovoy; Marvin R. (San Anselmo, CA), Haroldsen; Peter E. (Pacifica, CA), Musson; Donald G. (Greenbrae, CA) |
Assignee: | SERB SA (Brussels, BE) |
Application Number: | 14/128,672 |
Patent Claim Types: see list of patent claims | Use; Dosage form; |
Drugs Protected by US Patent 10,793,893
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Catalyst Pharms | FIRDAPSE | amifampridine phosphate | TABLET;ORAL | 208078-001 | Nov 28, 2018 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | METHOD OF TREATING LAMBERT-EATON MYASTHENIC SYNDROME WITH AMIFAMPRIDINE | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 10,793,893
PCT Information | |||
PCT Filed | June 29, 2012 | PCT Application Number: | PCT/US2012/044904 |
PCT Publication Date: | January 03, 2013 | PCT Publication Number: | WO2013/003708 |
International Family Members for US Patent 10,793,893
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Canada | 2840591 | ⤷ Try a Trial | |||
World Intellectual Property Organization (WIPO) | 2013003708 | ⤷ Try a Trial | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |